Byotrol Plc
("Byotrol" or the
"Company")
Results of General
Meeting
Byotrol Plc (AIM: BYOT), the
specialist infection prevention and control company, announces that
at the Company's General Meeting held earlier today all resolutions
were duly passed.
In accordance with the passing of
Resolution 1, the Capital Reorganisation will become effective at
the close of business today.
In accordance with the passing of
Resolution 3, cancellation of admission of the Company's ordinary
shares to trading on AIM will become effective at 7.00am on 30
April 2024. In accordance with the passing of Resolution 2,
the Company will re-register as a private limited company with the
name Byotrol Limited which is expected to take place by 21 May
2024.
The voting details with regards the
General Meeting resolutions will be detailed on the Company's
website, www.byotrol.com
Shareholders are reminded that the last day of dealings in
Byotrol Plc ordinary shares on AIM will be 29 April
2024.
With effect from the cancellation of
admission of the Company's ordinary shares to trading on AIM, the
Company expects to implement a matched bargain facility in order to
facilitate future trading in its shares. A further announcement
will be made in due course.
Further details of the cancellation
and re-registration are set out in the circular dated 28 March 2024
("the Circular"). A copy of the Circular is available on the
Company's website www.byotrol.com
Unless otherwise indicated, defined
terms in this announcement shall have the same meaning as described
in the Circular.
For
further information contact:
|
Byotrol Plc
|
|
|
Dr Trevor Francis, Non- Executive
Chairman
|
+44
(0)1925 742 000
|
|
David Traynor, Interim Chief
Executive Officer
Chris Sedwell, Chief Financial
Officer
|
|
|
|
|
|
Cavendish Capital Markets Limited (Nominated Adviser and
Broker)
|
+44 (0)20
7220 0500
|
|
Geoff Nash/George Dollemore -
Corporate Finance
Nigel Birks/Harriet Ward -
ECM
|
|
|
|
|
|
|
|
|
Flagstaff Strategic and Investor
Communications
|
+44 (0)20
7129 1474
|
|
Tim Thompson/Andrea Seymour/Fergus
Mellon
|
byotrol@flagstaffcomms.com
|
This announcement is released by Byotrol Plc and, prior to
publication, the information contained herein was deemed to
constitute inside information under the Market Abuse Regulations
(EU) No. 596/2014. Such information is disclosed in accordance with
the Company's obligations under Article 17 of
MAR.
Notes to
editors
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection
prevention and control company, operating globally in the animal
and human healthare, industrial, institutional and consumer
sectors, providing low toxicity products with a broad-based and
targeted efficacy across all microbial classes; bacteria, viruses
(including coronavirus), fungi, moulds, mycobacteria and
algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where they can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, go to byotrol.com